Document is current
Any future updates will be listed below
-
Authors
Aw, Daryl Zheng Hao
Zhang, Denzel Xugeng
Vignuzzi, Marco
-
Funding
Funding for this research was provided by:
National Research Foundation Investigatorship Award (NRF-NRFI08-2022-0005)
- License Information
-
More Information
Article History
Received: 26 November 2024
Accepted: 21 May 2025
First Online: 9 June 2025
Competing interests
: All three authors have current ongoing collaborations with DeNovo Biosciences and Recursion, two AI antiviral drug discovery companies. There was no bias towards any of the work directly performed by these companies, and is not covered in this review.
